Intact neuronal function in Rheb1 mutant mice: implications for TORC1-based treatments.

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• The target of rapamycin complex 1 (TORC1) pathway regulates neuronal function, impacting synaptic plasticity, learning, and memory.
• TORC1 inhibitors show therapeutic potential for developmental disorders, aging, epilepsy, and cancer, necessitating an understanding of long-term effects.

Purpose of the Study:

• To investigate the impact of sustained TORC1 hypo-activation on brain development and cognitive function.
• To determine the effects of prolonged, specific reduction in TORC1 signaling on synaptic plasticity and learning.

Main Methods:

• Utilized constitutive and conditional Rheb1 mutant mice to model prolonged TORC1 pathway reduction.
• Assessed brain development, synaptic plasticity, and hippocampus-dependent learning and memory in mutant mice.

Main Results:

• Rheb1 mutant mice exhibited up to a 75% reduction in TORC1 signaling.
• These mice demonstrated normal brain development and maintained intact synaptic plasticity and learning and memory functions.
• Cognitive function remained unaffected by sustained, specific down-regulation of TORC1 activity.

Conclusions:

• Sustained and specific down-regulation of TORC1 activity does not adversely affect cognitive function or brain development.
• Unlike TORC1 hyper-activity, cognitive function shows resilience to reduced TORC1 signaling.
• Findings provide critical insights into the safety and efficacy of TORC1-targeting therapies.